Mesenchymal stem cells (MSCs) are multipotent stem cells with a high capacity for self-renewal. They can develop into specialized cells of the body such as chondrocytes, osteoblasts, and adipocytes, and their easy accessibility, exceptional genomic stability, and capacity for tissue repair with few immunological and ethical issues make them a favorable cell type for experimental and clinical use. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) have advantages over traditional sources of MSCs, including ease of collection, faster self-renewal, longer multipotency, and additional immunosuppressive properties, making them potentially beneficial in regenerative medicine and tissue engineering.
UC-MSCs were isolated from the umbilical cord tissue of a neonatal (day 0) female canine. The cells are cultured, passaged for purity, cryopreserved, and delivered frozen. Each vial contains 1 x 106 cells in 1 mL volume. Cells are characterized by flow cytometry for CD90, CD105, CD44, CD45, and CD34. UC-MSCs are negative for mycoplasma, yeast, fungi, and bacteria. Cells are assured to further culture using the protocol provided by JangoCell.